Mount Lucas Management LP acquired a new position in Alpha Teknova, Inc. (NASDAQ:TKNO – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 9,000 shares of the company’s stock, valued at approximately $75,000.
Several other institutional investors have also recently bought and sold shares of TKNO. Point72 Asset Management L.P. bought a new stake in shares of Alpha Teknova during the 3rd quarter valued at $1,483,000. Geode Capital Management LLC raised its position in shares of Alpha Teknova by 24.4% during the 3rd quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after acquiring an additional 36,914 shares during the last quarter. Raymond James Financial Inc. bought a new stake in shares of Alpha Teknova during the 4th quarter valued at $716,000. State Street Corp raised its position in shares of Alpha Teknova by 249.3% during the 3rd quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after acquiring an additional 54,700 shares during the last quarter. Finally, Nkcfo LLC bought a new stake in shares of Alpha Teknova during the 4th quarter valued at $501,000. Institutional investors own 13.81% of the company’s stock.
Wall Street Analyst Weigh In
Separately, Craig Hallum started coverage on shares of Alpha Teknova in a research report on Monday, February 10th. They set a “buy” rating and a $12.00 target price for the company.
Alpha Teknova Price Performance
Shares of TKNO stock opened at $5.52 on Tuesday. Alpha Teknova, Inc. has a 12-month low of $1.16 and a 12-month high of $10.37. The firm has a market capitalization of $294.26 million, a price-to-earnings ratio of -7.46 and a beta of 0.41. The company has a quick ratio of 3.94, a current ratio of 4.73 and a debt-to-equity ratio of 0.12. The firm has a fifty day moving average of $8.04 and a 200-day moving average of $6.91.
Alpha Teknova (NASDAQ:TKNO – Get Free Report) last announced its quarterly earnings results on Tuesday, March 4th. The company reported ($0.11) earnings per share (EPS) for the quarter. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. The firm had revenue of $9.27 million during the quarter, compared to analyst estimates of $9.10 million. On average, equities research analysts forecast that Alpha Teknova, Inc. will post -0.58 earnings per share for the current year.
Alpha Teknova Profile
Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.
Further Reading
- Five stocks we like better than Alpha Teknova
- The Most Important Warren Buffett Stock for Investors: His Own
- How to Protect Your Portfolio When Inflation Is Rising
- Using the MarketBeat Stock Split Calculator
- 3 Tech Stocks Defying Sector Weakness and Thriving in 2025
- Short Selling: How to Short a Stock
- Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors
Want to see what other hedge funds are holding TKNO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Alpha Teknova, Inc. (NASDAQ:TKNO – Free Report).
Receive News & Ratings for Alpha Teknova Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Teknova and related companies with MarketBeat.com's FREE daily email newsletter.